Full Press Release Details
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
AMLX Neutral Sentiment
Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
Key Takeaway: Amylyx Pharmaceuticals has announced that it will report its financial results for the second quarter of 2026 on August 6, 2026. This announcement is part of their regular financial reporting schedule. The company is based in Cambridge, Massachusetts, and is focused on developing therapies for neurological diseases.
Price reaction · baseline $20.31 (2026-07-31 close) · hit pre-market · clean, no other AMLX news in the window
day 0 close · peak
-0.7%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+167%
120-day peak, hindsight
Typical move
4.4%
average across 3 past catalysts
Cash runway
~20 mo
Low dilution risk
Lead asset
AMX0114
Phase 1 · ALS
Frequently Asked Questions
When will Amylyx report its Q2 2026 financial results?
Amylyx Pharmaceuticals will report its Q2 2026 financial results on August 6, 2026.
Where is Amylyx Pharmaceuticals located?
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts.